Vivo Opportunity Fund Holdings, L.P. - 07 Jan 2026 SCHEDULE 13G/A Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value (CDTX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Cidara Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
CDTX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 18:11:15 UTC
Date of event
07 Jan 2026
Previous filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 0% 0 0 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 0% 0 0 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0% 0 0 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman Fund, L.P., General Partner
Vivo Opportunity Cayman, LLC 0% 0 0 0 /s/ Kevin Dai Kevin Dai/Managing Member